MANUFACTURERS
Pharmacom Labs BTW Labs A-Tech Labs Pharmaqo Stealth Labs Tiger Pharma ZPHC Hubio Pharm Ultima Pharma Dragon Pharma Nakon Medical Unique Pharma Driada Medical Deus Medical Shree Venkatesh Xeno Labs Sixpex Axio Labs British Dragon Kalpa Pharmaceuticals Beligas Hilma Biocare Euro-Pharmacies Peptide Hubs Ozpharm Biaxol Supplements Para Pharma SP Labs Somatrop-Lab Abbott Abdi Ibrahim Aburaihan Agrosaf Aksufarma Ilac San Allaes Allergan Ali Raif Alium Alpha Pharma Anke Bio American Remedies Amgen Apex Pharma Aptissen Astellas AstraZeneca Ajanta Pharma Alkem Laboratories Alto Aurochem Laboratories Argis Aspen Assos Atabay Ayset Balkan Pharmaceuticals Banford Bayer Bayer Zydus Pharma Becton Dickinson Belmed Berko Berlin-Chemie Besins Bilim Bioamino Labs Biocon Biologics BioTeq Labs Bharat Serums And Vaccines Boehringer Cadila Pharma Canada Peptides Celon Labs Centurion Laboratories Cipla Concern Pharma Conventional Syringes Daewoong Daiichi Sankyo Darnitsa Deva Dharam Distributors Dong-A Dosfarm Dr. Morepen Drogsan Drooc Pharma Dr. Reddy's Laboratories Eczacıbaşı Eisai Elikem Embil Europe GT Evalar Farmak Ferring Fidia Fortune Health Care Galenika German Remedies Genetic Pharma Genopharm GenSci Generics Grindex GSK HAB Pharma Hansel Healing Pharma Hemat Himalaya Hygene Pharma IBSA Ice Pharma Innventa Pharm Ipsen Intas Biopharmaceuticals Iran Hormone Jelfa Johnlee Pharmaceuticals Kachhela Pharmaceuticals Kanonpharma Kocak Farma Knoll Healthcare KRKA Leeford Healthcare Liba Lilly Livzon Lizhu Bio Lupin Laboratories Macleods Mankind Pharma Marten Meda Pharma Menarini Merck MSD Mustafa Nevzat Natco Pharma Neutec Nobel Novartis Novo Nordisk Odin Anabolics Omstal Pharma Organon Orion Corp Orva Ozon Parex Pharmacia & Upjohn Pharmacy Turkish Pfizer Procter & Gamble Pliva Ranbaxy Reliance Lifesciences RJ Bio Roche RSM Pharma Satan Pharma Samarth Lifesciences Sandoz Sanofi Aventis Sanovel Schonen Scott Edil Pharmacia LTD Searle Interphar Serono Servier SFM Signature Spectrum Pharma Sopharma Sun Pharma Sunrise Remedies Singani Pharma Takeda Teva Pharmaceutical Torrent Pharmaceuticals UCB USV (United States Vitamin) Vipro Lifescience Xantis Pharma Zerox Pharma Zdorovje Zee Laboratories Zydus Cadila Healthcare

Semaglutide

Shipping options
$89.00
Quanity:
Log in to subscribe for notifications
Shipping options

Characteristics

ACTIVE HALF-LIFE
7 days
Classification
Weight lose
Dosage
0.25mg once per week
Active Substance
FORM
2mg/vial + 2 ml water
Manufacturer

Description

SEMAGLUTIDE - BIOAMINO LABS

 

1 vial x 2 mg (powder) + 1 vial  x 2 ml injection water

 

Compound name : Semaglutide (GLP-1)

This agent "Semaglutide" gets classified along with other poly-peptides, yet it's more recognized and known as a GLP-1 receptor agonist.  It possesses the ability that mimics the very action of human incretin glucagon-like peptide-1 "GLP-1" (the classification that was mentioned prior).

 

Using this agent could be something that athletes could consider when they/you are greatly considering ways to lose weight, now for this exact reason is why Semaglutide is being used as an "anti-obesity medication" (When structured with a health nutritional intake/good diet and exercise design). It's a compound that will assist with glycemic control.

During phases when athletes are trying to significantly lose weight, and at times attempting to dramatically increase size/weight (bulking phases), glycemic assistance could help a mammoth amount.

PSL's Semaglutide (GLP-1) will help your pancreas release the appropriate/right amount of insulin when your blood sugar is high. This will help your body produce the correct amount of insulin that is utmost needed.

This agent will truly support you with avoiding chronically high levels of blood sugar, in turn this will reduce any potential issues that could have severe impacts on your underlying health.

GREAT when used for weight loss or BULKING..

Usual Adult Dose for Weight Loss -

Initial Dose Escalation Schedule:

 - Weeks 1 through 4: 0.25 mg subcutaneously once a week

 

 - Weeks 5 through 8: 0.5 mg subcutaneously once a week

 

 - Weeks 9 through 12: 1 mg subcutaneously once a week

 

 - Weeks 13 through 16: 1.7 mg subcutaneously once a week

 

Maintenance Dose:

 

 - Week 17 and onward: 2.4 mg subcutaneously once a week

 

Dosing Considerations:

 

 - If dose escalation is not tolerated, consider delaying dose escalation for 4 weeks

 

 - If the maintenance dose of 2.4 mg once a week is not tolerated, the dose can be temporarily decreased to 1.7 mg once a week for a maximum of 4 weeks

 

 - After 4 weeks, increase dose back to 2.4 mg once a week; discontinue therapy if the patient cannot tolerate the maintenance dose of 2.4 mg once a week

 

Semaglutide's half-life in the blood is about seven days (165–184 hours).

Customer Reviews


Customers who bought this item also bought:

Back to top